DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

ImmunoGen (NASDAQ: IMGN)

company name or ticker

Biotech Investors: May 29th Could Be A Big Day

Will Amgen (AMGN) Keep Earnings Streak Alive in 1Q? - Analyst Blog

5 Biotech Earnings Under The Microscope This Week

Best Pure Play Investment in Cancer Drugs

Global cancer drug sales could soon soar past $100 billion, making this pure play in cancer drugs a stock you should seriously consider owning.

Will Pharmaceutical Sales Drive J&J (JNJ) Earnings Again? - Analyst Blog

'Mad Money' Lightning Round: Buy, Buy, Buy Starbucks, AT&T

1 Small-Cap Biotech Stock to Buy and Hold For the Next 10 Years

Small cap biotech stocks have a lot of inherent risk, but if you can snag a winner your returns could double many times over. Here's one small-cap biotech stock you can consider buying and holding for the next 10 years.

5 Promising Biotech Stocks Under $10

Don't let their share price fool you. These five biotech stocks have the potential to double your money many times over if their product pipelines meet expectations.

Bind Therapeutics Inc, Noble Energy, Inc., Others Are Moving After-Hours

ImmunoGen (IMGN) in Focus: Stock Rises 5.1% in Session - Tale of the Tape

See More Articles...